Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AGIOS PHARMACEUTICALS, INC. (AGIO)

  • Business News
  • June 29, 2026, 11:00 UTC
  • 1
  • 1 comments

Agios to Host Second Quarter 2026 Financial Results Conference Call and Webcast on July 30 at 8:00 a.m. ET

Market reaction Comment Full text

GLOBAL PHARMATECH, INC. (OTCM)

  • Business News
  • June 29, 2026, 11:00 UTC
  • 2
  • 1 comments

OTC Markets Group Welcomes Surge Energy Inc. to OTCQX

Market reaction Comment Full text

BITDEER TECHNOLOGIES GROUP (BTDR)

  • Business News
  • June 29, 2026, 11:00 UTC
  • 2
  • 1 comments

Bitdeer Technologies Group Signs Colocation Lease Agreement for Tydal, Norway AI Data Center Site

Market reaction Comment Full text

AIAI HOLDINGS CORP (AIAI)

  • Business News
  • June 29, 2026, 11:00 UTC
  • 3
  • 1 comments

NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company

Market reaction Comment Full text

ADMA BIOLOGICS, INC. (ADMA)

  • Business News
  • June 29, 2026, 11:00 UTC
  • 3
  • 1 comments

ADMA INVESTOR NOTICE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Market reaction Comment Full text

PALLADYNE AI CORP. (PDYN)

  • Business News
  • June 29, 2026, 11:00 UTC
  • 2
  • 1 comments

Palladyne AI’s GuideTech Wins New $2.3 Million Contract for BRAIN with Defense Prime Continuing Commercial Momentum

Market reaction Comment Full text

VENU HOLDING CORP (VENU)

  • Business News
  • June 29, 2026, 11:00 UTC
  • 3
  • 1 comments

VENU Joins Russell 3000 and Russell 2000 Indexes

Market reaction Comment Full text

I-MAB (NBP)

  • Business News
  • June 29, 2026, 11:00 UTC
  • 2
  • 1 comments

NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer

Market reaction Comment Full text

DIANTHUS THERAPEUTICS, INC. /DE/ (DNTH)

  • Business News
  • June 29, 2026, 11:00 UTC
  • 2
  • 1 comments

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis

Market reaction Comment Full text

COMMERCE BANCSHARES INC /MO/ (CBSH)

  • Business News
  • June 29, 2026, 11:00 UTC
  • 2
  • 1 comments

Commerce Bank to Acquire Nolan & Associates, Adding Investment Banking Capabilities for Middle-Market Clients

Market reaction Comment Full text
  • Previous
  • 3808
  • 3809
  • 3810
  • 3811
  • 3812
  • Next

Search

News categories

  • Technical Exchange News(14694)
  • Event(6229)
  • SEC News(393628)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(239526)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin